代谢组学预测COVID-19中抗病毒药物疗效 - Suppr

Suppr

超能文献

Metabolomics to Predict Antiviral Drug Efficacy in COVID-19.

作者信息

Migaud Marie, Gandotra Sheetal, Chand Hitendra S, Gillespie Mark N, Thannickal Victor J, Langley Raymond J

机构信息

University of South Alabama Mobile, Alabama.

University of Alabama Birmingham Birmingham, Alabama and.

出版信息

Am J Respir Cell Mol Biol. 2020 Sep;63(3):396-398. doi: 10.1165/rcmb.2020-0206LE.

DOI:10.1165/rcmb.2020-0206LE

PMID:32574504

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7462337/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2042/7462337/a83494104044/rcmb.2020-0206LE_f1.jpg

相似文献

Metabolomics to Predict Antiviral Drug Efficacy in COVID-19.

Am J Respir Cell Mol Biol. 2020 Sep;63(3):396-398. doi: 10.1165/rcmb.2020-0206LE.

Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.

Heredity (Edinb). 2020 May;124(5):619-620. doi: 10.1038/s41437-020-0314-z. Epub 2020 Apr 6.

Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action.

Naunyn Schmiedebergs Arch Pharmacol. 2020 Jul;393(7):1153-1156. doi: 10.1007/s00210-020-01902-5. Epub 2020 May 27.

[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].

Virologie (Montrouge). 2020 Jun 1;24(3):135-141. doi: 10.1684/vir.2020.0843.

Sofosbuvir for COVID-19 infection: A potential candidate.

Indian J Pharmacol. 2020 May-Jun;52(3):232-233. doi: 10.4103/ijp.IJP_675_20. Epub 2020 Aug 4.

Statin therapy and SAR-COV-2: an available and potential therapy?

Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):333-334. doi: 10.1093/ehjcvp/pvaa050.

Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection.

Int J Antimicrob Agents. 2020 Jun;55(6):105971. doi: 10.1016/j.ijantimicag.2020.105971. Epub 2020 Apr 10.

Rapid repurposing of drugs for COVID-19.

Science. 2020 May 22;368(6493):829-830. doi: 10.1126/science.abb9332. Epub 2020 May 8.

A Review of Remdesivir for COVID-19: Data to Date.

Cardiol Rev. 2020 Nov/Dec;28(6):332-334. doi: 10.1097/CRD.0000000000000337.

Statins in coronavirus outbreak: It's time for experimental and clinical studies.

Pharmacol Res. 2020 Jun;156:104803. doi: 10.1016/j.phrs.2020.104803. Epub 2020 Apr 11.

引用本文的文献

Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers.

Metabolomics. 2024 Dec 4;21(1):3. doi: 10.1007/s11306-024-02195-y.

Dysregulated nicotinamide adenine dinucleotide metabolome in patients hospitalized with COVID-19.

Aging Cell. 2024 Dec;23(12):e14326. doi: 10.1111/acel.14326. Epub 2024 Oct 1.

Emerging Landscape of Preclinical Models for Studying COVID-19 Neurologic Diseases.

ACS Pharmacol Transl Sci. 2023 Sep 6;6(10):1323-1339. doi: 10.1021/acsptsci.3c00127. eCollection 2023 Oct 13.

A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study.

Front Public Health. 2023 Jun 2;11:1145138. doi: 10.3389/fpubh.2023.1145138. eCollection 2023.

Crosstalk between COVID-19 Infection and Kidney Diseases: A Review on the Metabolomic Approaches.

Vaccines (Basel). 2023 Feb 20;11(2):489. doi: 10.3390/vaccines11020489.

Spectroscopic methods for COVID-19 detection and early diagnosis.

Virol J. 2022 Sep 22;19(1):152. doi: 10.1186/s12985-022-01867-2.

A review of mass spectrometry-based analyses to understand COVID-19 convalescent plasma mechanisms of action.

Proteomics. 2022 Sep;22(18):e2200118. doi: 10.1002/pmic.202200118. Epub 2022 Jul 15.

Sera Metabolomics Characterization of Patients at Different Stages in Wuhan Identifies Critical Biomarkers of COVID-19.

Front Cell Infect Microbiol. 2022 May 2;12:882661. doi: 10.3389/fcimb.2022.882661. eCollection 2022.

Treatment of SARS-CoV-2-induced pneumonia with NAD and NMN in two mouse models.

Cell Discov. 2022 Apr 29;8(1):38. doi: 10.1038/s41421-022-00409-y.

COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?

Int J Mol Sci. 2022 Apr 13;23(8):4309. doi: 10.3390/ijms23084309.

本文引用的文献

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.

Cell. 2020 Jul 9;182(1):59-72.e15. doi: 10.1016/j.cell.2020.05.032. Epub 2020 May 28.

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.

Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.

Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.

Candidate drugs against SARS-CoV-2 and COVID-19.

Pharmacol Res. 2020 Jul;157:104859. doi: 10.1016/j.phrs.2020.104859. Epub 2020 Apr 29.

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.

Therapeutic options for the 2019 novel coronavirus (2019-nCoV).

Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0.

Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle.

Cell Metab. 2016 Aug 9;24(2):269-82. doi: 10.1016/j.cmet.2016.07.005.

Coronaviruses: an overview of their replication and pathogenesis.

Methods Mol Biol. 2015;1282:1-23. doi: 10.1007/978-1-4939-2438-7_1.

Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes.

Am J Respir Crit Care Med. 2014 Aug 15;190(4):445-55. doi: 10.1164/rccm.201404-0624OC.

Metabolomic derangements are associated with mortality in critically ill adult patients.

PLoS One. 2014 Jan 30;9(1):e87538. doi: 10.1371/journal.pone.0087538. eCollection 2014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验